Northern Trust
BBNX

Northern Trust’s Beta Bionics BBNX Stock Holding History

Northern Trust’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.2M Buy
331,956
+36,138
+12% +$430K ﹤0.01% 2599
2026
Q1 		$2.96M Buy
295,818
+11,365
+4% +$168K ﹤0.01% 2752
2025
Q4 		$8.67M Sell
284,453
-13,607
-5% -$363K ﹤0.01% 2158
2025
Q3 		$5.92M Buy
298,060
+202,807
+213% +$3.56M ﹤0.01% 2401
2025
Q2 		$1.39M Sell
95,253
-16,234
-15% -$230K ﹤0.01% 3208
2025
Q1 		$1.36M Buy
+111,487
New +$2.08M ﹤0.01% 3128

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Northern Trust's BBNX Position: Q2 2026 in Review

Northern Trust increased its Beta Bionics (BBNX) stake by 12% in Q2 2026, buying an estimated $430K and bringing the position to 331,956 shares worth $5.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2599.

Northern Trust first reported a position in BBNX in Q1 2025 and has held it in 6 quarters since. The position peaked at $8.67M in Q4 2025. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Northern Trust held 331,956 shares of Beta Bionics worth $5.2M as of Q2 2026.
  • Northern Trust bought 36,138 Beta Bionics shares in Q2 2026, an estimated $430K.
  • Beta Bionics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2599 holding.
  • Northern Trust first reported a position in Beta Bionics in Q1 2025 and has held it in 6 quarters since.
  • Northern Trust's Beta Bionics position peaked at $8.67M in Q4 2025.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.